May 8, 2018 / 10:43 PM / in 3 months

BRIEF-Sunesis Pharmaceuticals Qtrly Loss Per Share $0.21

May 8 (Reuters) - Sunesis Pharmaceuticals Inc:

* SUNESIS PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND RECENT HIGHLIGHTS

* Q1 REVENUE $200,000 VERSUS I/B/E/S VIEW $200,000

* QTRLY LOSS PER SHARE $0.21 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below